Kochav Defense Acquisition Corp. (KCHV) · Oct 28, 2026 · Other events
$0.06/share trust contribution — $0.06 per non-redeemed share for the first three months; up to $300,000
Kochav’s extension filing adds sponsor cash to the trust account, improving redemption economics but underscoring that no business combination is signed yet.
Kochav is still a blank-check company searching for a defense or aerospace acquisition, with no definitive business-combination agreement disclosed and a proposed extension from November 29, 2026 to November 29, 2027. The filing improves the economics of staying in. If shareholders approve the extension, the sponsor will add $0.06 per non-redeemed public share for the first three months, capped at $300,000, then $0.02 per share per month thereafter, capped at $100,000 monthly. That is genuinely new versus the October 19 proxy, which offered no sponsor trust contribution, so it gives holders an incremental reason not to redeem before the vote.
But this is a financing sweetener, not business progress. The filing does not identify a target, sign a merger agreement, or shorten the path to a transaction; it mainly tries to secure more time. The sponsor’s planned conversion of 8,433,332 Class B shares into Class A shares preserves the same transfer restrictions, redemption waiver, and voting obligations. 〔0〕 That alignment helps the vote mechanics, but does not change the underlying absence of a deal.
The signal is therefore two-sided. The added trust cash is modestly better for shareholders who remain invested, while the need to amend the proposal after the proxy was filed suggests the extension requires extra persuasion. The next hard test is the extraordinary general meeting scheduled for November 13, 2026. 〔1〕
Bottom line: This makes the extension proposal more attractive, but it does not advance Kochav toward an actual defense or aerospace transaction. The meaningful new information is the sponsor cash contribution—not a new deal or a clearer target.
November 13, 2026 shareholder vote
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!